Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma.
about
Clinical utilities and biological characteristics of melanoma sentinel lymph nodesProgrammed cell death protein-1/programmed cell death ligand-1 pathway inhibition and predictive biomarkers: understanding transforming growth factor-beta roleChinese Guidelines on the Diagnosis and Treatment of Melanoma (2015 Edition)Lymphatic Vessels, Inflammation, and Immunity in Skin CancerReflections on the Histopathology of Tumor-Infiltrating Lymphocytes in Melanoma and the Host Immune ResponseInnate and adaptive immune cells in the tumor microenvironmentThe STING pathway and the T cell-inflamed tumor microenvironmentMelanoma Risk and Survival among Organ Transplant Recipients.Molecular Pathways: Targeting the Stimulator of Interferon Genes (STING) in the Immunotherapy of CancerAssociation of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapyClinical and biological determinants of melanoma progression: Should all be considered for clinical management?Data set for pathology reporting of cutaneous invasive melanoma: recommendations from the international collaboration on cancer reporting (ICCR).Twelve-year survival and immune correlates in dendritic cell-vaccinated melanoma patients.Digital genomic quantification of tumor-infiltrating lymphocytes.Melanoma: tumor microenvironment and new treatments.Analysis of immune status after iodine-125 permanent brachytherapy in prostate cancerAcquired IFNγ resistance impairs anti-tumor immunity and gives rise to T-cell-resistant melanoma lesions.Gamma-interferon-inducible lysosomal thiol reductase is upregulated in human melanomaAge as a predictor of sentinel node metastasis among patients with localized melanoma: an inverse correlation of melanoma mortality and incidence of sentinel node metastasis among young and old patients.The role of immunotherapy in solid tumors: report from the Campania Society of Oncology Immunotherapy (SCITO) meeting, Naples 2014Genomic Classification of Cutaneous MelanomaFrequency and characteristics of familial melanoma in Spain: the FAM-GEM-1 Study.Increased NY-ESO-1 expression and reduced infiltrating CD3+ T cells in cutaneous melanoma.Characterization of the Microenvironment in Positive and Negative Sentinel Lymph Nodes from Melanoma Patients.More Accurate Prediction of Metastatic Pancreatic Cancer Patients' Survival with Prognostic Model Using Both Host Immunity and Tumor Metabolic ActivityAbsence of Tumor-Infiltrating Lymphocyte Is a Reproducible Predictive Factor for Sentinel Lymph Node Metastasis: A Multicenter Database Study by the Brazilian Melanoma GroupIdentification of characteristic TRB V usage in HBV-associated HCC by using differential expression profiling analysisProfiling networks of distinct immune-cells in tumors.A miRNA-Based Signature Detected in Primary Melanoma Tissue Predicts Development of Brain Metastasis.Revisiting determinants of prognosis in cutaneous melanoma.Integrative analysis of breast cancer reveals prognostic haematopoietic activity and patient-specific immune response profilesCancer immunoprevention.Pretreatment Neutrophil to Lymphocyte Ratio Independently Predicts Disease-specific Survival in Resectable Gastroesophageal Junction and Gastric AdenocarcinomaThe host STING pathway at the interface of cancer and immunityTumor-infiltrating lymphocyte grade in primary melanomas is independently associated with melanoma-specific survival in the population-based genes, environment and melanoma study.Impact of aging on host immune response and survival in melanoma: an analysis of 3 patient cohorts.The Role of the Tumor Vasculature in the Host Immune Response: Implications for Therapeutic Strategies Targeting the Tumor Microenvironment.Clinicopathological significance of intratumoral and peritumoral lymphocytes and lymphocyte score based on the histologic subtypes of cutaneous melanoma.Prognosis of patients with melanoma and microsatellitosis undergoing sentinel lymph node biopsy.Lymphatic biomarkers in primary melanomas as predictors of regional lymph node metastasis and patient outcomes.
P2860
Q26747723-F2F81E3A-B95A-4421-8CEC-0012E45E3B0BQ26769734-D1637559-A070-4C28-955C-A2BCFD26D6D6Q26770492-0FE6E2D5-D0CE-46A2-B89B-595315FF4BF1Q26778332-AFEA8E1C-2A32-4525-B03A-048E31B4171EQ26799073-640BB641-6C58-4C68-9AB5-93CCAEDE31EAQ27008342-8999B7DE-61B3-4E49-BB3E-2A314C32878EQ27008371-EDB69FDD-D33B-46C0-AACC-60C83DF025ADQ27320787-AC636CDB-BF9E-4234-B07B-CDD49A9B42D9Q28080773-4DF1FA0F-A6EE-4B8B-A5B0-7150C1335FF1Q29617774-4A8C0C16-872F-4C6F-9693-2C4E0E0C0C62Q30252150-5B53DDF5-17D9-4BC6-A3E0-38F5F8715D05Q30669529-82C433F1-D5AF-462A-9F93-B724D40EEF99Q30846001-C43998C8-53C5-444B-AA6C-7AECE74FA15BQ33631158-8EF9FBB6-08E4-4E44-8D6B-9CD1413F770EQ33675676-3590250E-7590-49C5-88DF-161D6B254D26Q33707786-66AE37DE-BFA8-4D95-BF40-AA64A2CAC247Q33766695-CB8776C0-5789-4ECE-83F1-653E84266E87Q33788644-62B738E9-FCE5-45CE-AD1A-312850BCCD2AQ34000266-BF68753E-9D89-46F3-B28F-CF2F6CF2C230Q34402325-D97FB7D1-DB86-4E6C-B8A6-04BCAF45388FQ34670776-8A7D4FC1-7509-48F5-98C1-43A41DAD688DQ35392953-443789C7-C108-49FC-8E51-1CF9BAACE24DQ35543740-0514CB5D-2745-4B83-BA9D-D84585074ACEQ35719855-06F97250-650F-4C39-9A83-6573B6C9F5B9Q35884149-758CD8C3-8275-433F-95FC-10D1D09B72EEQ35918156-3FCDF7CC-E9EA-44BA-B4C3-085773B0D4DCQ36060319-85EDA7B0-8730-453B-89E0-D4BECC05C101Q36067826-480B4A13-D403-4928-B217-9DBC28A44DACQ36244744-D7027F91-B1EA-4AA6-AAE1-1BE3C8CF323FQ36338825-E650FA00-F487-4A69-996A-517B09AF92D5Q36499105-D196283D-8D4E-43EA-A8F4-CFB038B9E1A9Q36723234-87224742-471C-47BA-97FA-81ED5A1DB61DQ36999075-81FB1EBC-1EF9-406D-8BD0-5E9849A2BF75Q37042237-940A92A2-0481-4FF5-A2A0-1F1B526745F7Q37289626-9E2AA658-543D-4214-BD13-8790CDA41A09Q37350143-F74AE353-345F-486F-B935-F25BE580C162Q37516448-E2E24326-5D49-4A82-A0CE-0A1921B74F70Q37716437-2E5ABBBC-7122-4469-B797-0EE514290A79Q37726003-700ED917-1C12-43C4-921F-D485BB0C4931Q38072488-8309163F-06D3-45D7-8432-5A21278081BA
P2860
Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Tumor-infiltrating lymphocyte ...... ients with cutaneous melanoma.
@en
Tumor-infiltrating lymphocyte ...... ients with cutaneous melanoma.
@nl
type
label
Tumor-infiltrating lymphocyte ...... ients with cutaneous melanoma.
@en
Tumor-infiltrating lymphocyte ...... ients with cutaneous melanoma.
@nl
prefLabel
Tumor-infiltrating lymphocyte ...... ients with cutaneous melanoma.
@en
Tumor-infiltrating lymphocyte ...... ients with cutaneous melanoma.
@nl
P2093
P356
P1476
Tumor-infiltrating lymphocyte ...... ients with cutaneous melanoma.
@en
P2093
Farhad Azimi
John F Thompson
Marc Moncrieff
Pavlina Rumcheva
Robyn P Saw
Stanley W McCarthy
P304
P356
10.1200/JCO.2011.37.8539
P407
P577
2012-06-18T00:00:00Z